JHC.AU · Japara Healthcare Limited

-

Please sign in to comment on JHC.AU

1 Comment

Admin

3 years, 7 months ago

Japara Healthcare Limited is currently in a long term uptrend where the price is trading 59.5% above its 200 day moving average.

From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.

Japara Healthcare Limited's total revenue rose by 15.4% to $213M since the same quarter in the previous year.

Its net income has dropped by 275.4% to $-10M since the same quarter in the previous year.

Finally, its free cash flow grew by 69.2% to $-9M since the same quarter in the previous year.

Based on the above factors, Japara Healthcare Limited gets an overall score of 4/5.

ISIN	AU000000JHC5
Industry	Medical Care Facilities
Sector	Healthcare
CurrencyCode	AUD
Exchange	AU

Dividend Yield	0.0%
Beta	2.27
Target Price	1.05
PE Ratio	None
Market Cap	380M

ABOUT

Japara Healthcare Limited

Japara Healthcare Limited, together with its subsidiaries, owns, develops, and operates residential aged care homes in Australia. It operates approximately 4,000 resident places across 50 homes, which include 33 homes in Victoria, seven homes in New South Wales, three homes in Queensland, five homes in South Australia, and two homes in Tasmania; and 180 independent living units across 5 retirement villages. The company was founded in 2005 and is based in Southbank, Australia. As of November 5, 2021, Japara Healthcare Limited operates as a subsidiary of Calvary Bruce Private Hospital Limited.

JHC.AU · Japara Healthcare Limited

-

Japara Healthcare Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Japara Healthcare Limited using a moving average strategy